LAKE OSWEGO, Ore., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Rosemary Mazanet, M.D., Ph.D., Chief Medical Officer, will provide a presentation entitled, "Immunotherapy for Minimal Residual Disease- a Breast Cancer Vaccine to Prevent or Delay Recurrence Following Adjuvant Therapy" at the Cancer Immunotherapy Summit. The presentation will take place on Wednesday, February 29, 2012 at 10:15 AM EST at the Metro Meeting Centers in Boston, MA.
